112 related articles for article (PubMed ID: 19346460)
1. How does Viagra protect the ischemic heart?
Xia Y
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1209-10. PubMed ID: 19346460
[No Abstract] [Full Text] [Related]
2. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.
Das A; Salloum FN; Xi L; Rao YJ; Kukreja RC
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1236-43. PubMed ID: 19286961
[TBL] [Abstract][Full Text] [Related]
3. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin.
Rosanio S; Ye Y; Atar S; Rahman AM; Freeberg SY; Huang MH; Uretsky BF; Birnbaum Y
Cardiovasc Drugs Ther; 2006 Feb; 20(1):27-36. PubMed ID: 16435070
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment of sildenafil attenuates ischemia-reperfusion renal injury in rats.
Choi DE; Jeong JY; Lim BJ; Chung S; Chang YK; Lee SJ; Na KR; Kim SY; Shin YT; Lee KW
Am J Physiol Renal Physiol; 2009 Aug; 297(2):F362-70. PubMed ID: 19474186
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular protection with sildenafil following chronic inhibition of nitric oxide synthase.
Kukreja RC
Br J Pharmacol; 2007 Mar; 150(5):538-40. PubMed ID: 17245364
[TBL] [Abstract][Full Text] [Related]
6. Regulation and role of myocyte cyclic GMP-dependent protein kinase-1.
Kass DA; Takimoto E
Proc Natl Acad Sci U S A; 2010 Jun; 107(24):E98; author reply E99. PubMed ID: 20498039
[No Abstract] [Full Text] [Related]
7. Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection.
Sánchez JA; Rodríguez-Sinovas A; Barba I; Miró-Casas E; Fernández-Sanz C; Ruiz-Meana M; Alburquerque-Béjar JJ; García-Dorado D
Basic Res Cardiol; 2013 May; 108(3):351. PubMed ID: 23595215
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling.
Das A; Xi L; Kukreja RC
J Biol Chem; 2005 Apr; 280(13):12944-55. PubMed ID: 15668244
[TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase 5 inhibition blocks pressure overload-induced cardiac hypertrophy independent of the calcineurin pathway.
Hsu S; Nagayama T; Koitabashi N; Zhang M; Zhou L; Bedja D; Gabrielson KL; Molkentin JD; Kass DA; Takimoto E
Cardiovasc Res; 2009 Feb; 81(2):301-9. PubMed ID: 19029137
[TBL] [Abstract][Full Text] [Related]
10. The phosphodiesterase 5 inhibitor sildenafil stimulates angiogenesis through a protein kinase G/MAPK pathway.
Pyriochou A; Zhou Z; Koika V; Petrou C; Cordopatis P; Sessa WC; Papapetropoulos A
J Cell Physiol; 2007 Apr; 211(1):197-204. PubMed ID: 17226792
[TBL] [Abstract][Full Text] [Related]
11. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway.
Bulhak AA; Jung C; Ostenson CG; Lundberg JO; Sjöquist PO; Pernow J
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H719-27. PubMed ID: 19151258
[TBL] [Abstract][Full Text] [Related]
12. Myocardial reperfusion injury management: erythropoietin compared with postconditioning.
Tamareille S; Ghaboura N; Treguer F; Khachman D; Croué A; Henrion D; Furber A; Prunier F
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2035-43. PubMed ID: 19617412
[TBL] [Abstract][Full Text] [Related]
13. Are the mechanisms for NO-dependent vascular remodeling different from vasorelaxation in vivo?
Schleicher M; Sessa WC
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1207-8. PubMed ID: 18565841
[No Abstract] [Full Text] [Related]
14. Oxidative stress regulates left ventricular PDE5 expression in the failing heart.
Lu Z; Xu X; Hu X; Lee S; Traverse JH; Zhu G; Fassett J; Tao Y; Zhang P; dos Remedios C; Pritzker M; Hall JL; Garry DJ; Chen Y
Circulation; 2010 Apr; 121(13):1474-83. PubMed ID: 20308615
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart.
Salloum F; Yin C; Xi L; Kukreja RC
Circ Res; 2003 Apr; 92(6):595-7. PubMed ID: 12637371
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase-5 inhibition abolishes neuron apoptosis induced by chronic hypoxia independently of hypoxia-inducible factor-1alpha signaling.
Caretti A; Bianciardi P; Ronchi R; Fantacci M; Guazzi M; Samaja M
Exp Biol Med (Maywood); 2008 Oct; 233(10):1222-30. PubMed ID: 18641057
[TBL] [Abstract][Full Text] [Related]
17. Preconditioning by phosphodiesterase-5 inhibition improves therapeutic efficacy of adipose-derived stem cells following myocardial infarction in mice.
Hoke NN; Salloum FN; Kass DA; Das A; Kukreja RC
Stem Cells; 2012 Feb; 30(2):326-35. PubMed ID: 22102597
[TBL] [Abstract][Full Text] [Related]
18. Mitigation of the progression of heart failure with sildenafil involves inhibition of RhoA/Rho-kinase pathway.
Chau VQ; Salloum FN; Hoke NN; Abbate A; Kukreja RC
Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2272-9. PubMed ID: 21398594
[TBL] [Abstract][Full Text] [Related]
19. Pressure-overload magnitude-dependence of the anti-hypertrophic efficacy of PDE5A inhibition.
Nagayama T; Hsu S; Zhang M; Koitabashi N; Bedja D; Gabrielson KL; Takimoto E; Kass DA
J Mol Cell Cardiol; 2009 Apr; 46(4):560-7. PubMed ID: 19159628
[TBL] [Abstract][Full Text] [Related]
20. Decreased activity of the Na+/H+ exchanger by phosphodiesterase 5A inhibition is attributed to an increase in protein phosphatase activity.
Yeves AM; Garciarena CD; Nolly MB; Chiappe de Cingolani GE; Cingolani HE; Ennis IL
Hypertension; 2010 Oct; 56(4):690-5. PubMed ID: 20713918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
